Find a participating AIRFLOW-3 Clinical Trial site or get the latest news and media updates on Nuvaira.

Locate a Clinic

Find a clinic near you that offers treatment with the dNerva Lung Denervation System as part of the AIRFLOW-3 Clinical Trial.

Treatment Locations in the United States

University of Alabama Lung Health Center
Birmingham, Alabama
Birmingham, Alabama
UC Davis Health
Sacramento, CA
Harbor-UCLA Medical Center
Torrance, CA
Ascension St. Vincent’s
Jacksonville, FL
The University of Chicago Medicine
Chicago, IL
AMITA Health Alexian Brothers Medical Center Elk Grove Village
Elk Grove Village, IL
University of Louisville Health
Louisville, KY
The Ohio State University Wexner Medical Center
Columbus, OH
University of Michigan Health
Ann Arbor, MI
Spectrum Health
Grand Rapids, MI
Beth Israel Lahey Health
Burlington, MA
Washington University Medical Center
St. Louis, MO
North Carolina
Duke University Medical Center
Durham, NC
Temple Health Lung Center
Philadelphia, PA
University of Pittsburgh Medical Center
Pittsburgh, PA
South Carolina
Medical University of South Carolina
Charleston, SC
Houston Methodist Hospital
Houston, TX
St. David’s Medical Center
Georgetown, TX

Treatment Locations in Europe

Klinik Floridsdorf
Vienna, Austria
Hopital de la Cavale Blanche
Brest, France
CHU de Grenoble
Grenoble, France
Hopital Arnaud de Villeneuve
Montpellier, France
Hopital Pasteur
Nice, France
Claude-Bernard – Hopital Bichat
Paris, France
CHU de Reims
Reims, France
Nouvel Hopital Civil
Strasbourg, France
Hopital Larrey
Toulouse, France
Thoraxklinik Universitätsklinikum Heidelberg
Heidelberg, Germany
University Medical Center Groningen
Groningen, Netherlands
Amsterdam UMC
Amsterdam, Netherlands
Royal Brompton Hospital
London, United Kingdom

Contact us to get more information on referring patients to the AIRFLOW-3 Clinical Trial. 

News and Media

Jun 10, 2019

First patients successfully treated in the Nuvaira AIRFLOW-3 COPD pivotal trial

A first for Temple University Hospital and U.S. Patients MINNEAPOLIS, June 10, 2019 – Nuvaira, developer of novel therapeutic strategies to treat obstructive…

May 02, 2019

Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, April 28, 2019 – Nuvaira, developer of novel therapeutic strategies to treat…

Feb 11, 2019

Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD

Market Development Veteran Lisa Rogan Joins Nuvaira’s Executive Team MINNEAPOLIS, Feb 11, 2019 – Nuvaira, a developer of novel therapeutic medical devices…

Discover if your patient may be a good fit for the AIRFLOW-3 clinical trial